Expertise

  • Analysis of drug concentrations
    close
    • Preparing urine samplesGas chromatography
    • HPLC
    • EMIT
    • LC/MS/MS
    • Radioimmunoassay
    • Drugs of abuse
    close

  • Bridging studies
    close

    Bridging studiesClick here to find out more about bridging studies.

    • Dedicated team of 12 bilingual Japanese nurses, graduates and recruiters
    • Most staff have 2-10 years’ experience of bridging studies
    • Incorporating Medical Volunteers Association (formerly InCROM Europe)
    • Database of 2,700 first generation Japanese volunteers
    • Experience of bridging studies in Japanese, Korean and Chinese subjects

    Download our Japanese language brochures:

    Click here to see our Japanese volunteer website.

    close

  • Cardiovascular
    close

    Hammersmith Medicines Research

    • Central ECG monitoring (SpaceLabs) on all beds
    • Telemetry (SpaceLabs) throughout premises
    • 12-lead ECG with electronic transfer capability
    • High-speed high-gain surface ECG
    • 24-h ambulatory 12-lead ECG and blood pressure monitoring
    • Exercise ECG
    • Passive tilt testing
    • Systolic time intervals
    • Impedance cardiography
    • Doppler aortic velography
    • Laser Doppler flowmetry
    • Forearm blood flow
    • Hand venous reflex measurement
    • Fingertip photo-plethysmography
    • Catecholamine and prostanoid agonist/antagonist trials
    • Thorough QT
    close

  • Central nervous system
    close

    P1vital

    close

  • Dermatological
    close

    Hammersmith Medicines Research

    • Transdermal bioavailability
    • Cutaneous irritancy and sensitisation
    • Extracellular fluid and skin drug pharmacokinetics
    • Penile sensitivity
    • Histamine, 5-HT or substance P intradermal tests
    • UV erythema challenge tests
    • Allergen tests
    close

  • Drug-drug interactions
    close

    Hammersmith Medicines Research

    • Digoxin, theophylline, warfarin
    • Oral contraceptives
    • Anticonvulsants
    • CYP3A4 inhibitors
    close

  • Gastrointestinal
    close

    Hammersmith Medicines Research

    • Intra-gastric and oesophageal ambulatory pH monitoring (24-h)
    • Pentagastrin- or histamine-stimulated acid secretion
    • Gastro-intestinal transit time
    • Intra-gastric drug infusion
    • Intra-jejunal drug administration
    • Faecal red blood cell loss (using 51Cr-labelled red cells)
    • Upper gastro-intestinal endoscopy
    • Ambulatory gastric emptying using caesium iodide detector, 99mTc radiolabelled meal and gamma camera
    • Gastric emptying using paracetamol kinetics
    • Gall bladder scintigraphy using 99mTc radiolabelled HIDA (in collaboration with Radiological Sciences Unit, Hammersmith Hospital)
    close

  • Haematological
    close

    Hammersmith Medicines Research

    • Bleeding time
    • Platelet aggregometry
    • FACS analysis
    • Red blood cell deformability
    • Coagulation trials
    • Cytokine assay
    • Assay of red and white blood cell precursors
    close

  • Microdosing
    close

    For microdose studies, we work with Xceleron UK, who provide the accelerator mass spectrometry service: http://www.xceleron.com

    Click here to find out more about microdosing.

    close

  • Ocular
    close
    • Non-contact tonometry
    • Goldmann applanation tonometry
    • Slit lamp examination
    • Photographic or twin-hole static pupillometry
    • Infrared static and dynamic pupillometry
    close

  • Positron Emission Tomography (PET)
    close

    PETWorking with Imanova, Hammersmith Hospital, on PET studies. Click here to find out more about PET.

    close

  • QT
    close

    Thorough QT studies

    Some people are born with prolonged QT interval, but others have prolonged QT interval thrust upon them - by medicines that affect cardiac repolarisation. QT prolongation predisposes to a disorganised heart rhythm called torsade de pointes, which can degenerate into ventricular fibrillation and death. In the last decade or so, several valuable drugs have been withdrawn from the market, or have had their use greatly restricted, because they can prolong QT interval and are associated with a risk of sudden death. Examples include prenylamine, terfenadine, astemizole, cisapride and sertindole.

    Regulatory authorities now expect to see a thorough QT study of a new medicine - a rigorous assessment of its potential to prolong QT interval - even if preclinical work shows no sign of any problem. At HMR, we have successfully completed many definitive studies of the potential of new medicines to cause QT prolongation. We use industry-standard MAC5000 ECG machines to record high quality digital 12-lead ECGs, which can be coded and analysed ‘blind’ by the sponsor’s choice of specialist contractor, anywhere in the world. We capture the 24h ambulatory ECG (Holter) using the ELA SyneFlash system, which records continuous 12-lead ECG. SyneFlash allows continuous beat-to-beat automated measurement of QT interval and hourly estimation of mean QT, with immediate online analysis of relationships between QT and RR intervals. In our definitive QT studies, we use repeat-dose regimens to achieve steady state. Sometimes we include a CYP3A4 inhibitor, such as ketoconazole. We maximise safety by keeping the subjects resident in our wards: our 16-channel Spacelabs ECG telemetry system allows us to monitor them continuously throughout the research facility. We have done many QT studies of new and existing medicines.

    Our track record shows that we can give sponsors the thorough QT study data that the regulators demand - safely, securely, and to strict timelines.

    Click here to find out more about QT.

    close

  • Radiolabelled
    close

    We offer a full service for phase 1 studies of radiolabelled products. We have long experience of studies with radiolabelled investigational medicinal products (IMPs) and non-IMPs. We have done more than 80 of them.

    • ADME: 14C, 125I and 3H (40 studies)
    • PET: 11C and 18F (30 studies)
    • radionuclide probe: 51Cr, 99mTc and 125I (10 studies)
    • microdose: 14C ‘light label’ (3 studies)

    Clinical facilities for radiolabelled studies

    • spacious new premises with separate areas for studies of ‘light label’ and conventional doses of radionuclide
    • integrated laboratory areas for processing samples

    Radiopharmacy

    • capsules
    • solutions and suspensions
    • sterile iv solutions

    Laboratory

    • liquid scintillation counting
    • support for ADME
    • QC of specific activity

    Staff

    • experienced staff: clinical, pharmacy, laboratory, QA, and radiation protection adviser

    Certification

    • ARSAC licence
    • Environment Agency licence
    • MHRA Supplementary Accreditation
    • MHRA Manufacturer’s Authorisation
    • College of American Pathologists

    Accreditation

    • ISO 9001 Quality Systemmicrodoses

    Click here to find out more about studies of radiolabelled products.

    close

  • Renal
    close

    Hammersmith Medicines Research

    • 51Cr - EDTA method for glomerular filtration rate
    • 125I - Hippuran method for effective renal plasma flow
    • Urinary transferrin, microalbumin and alpha-1-microglobulin to assess potential nephrotoxicity
    • Urinary enzyme assay - NAG
    • Renin and angiotensin assessments
    close

  • Respiratory
    close

    Hammersmith Medicines Research

    • Peak expiratory flow rate
    • Standard spirometry - Vitalograph Gold Standard
    • Computer-assisted spirometry
    • Nasal cannula Lung volumes by helium dilution
    • CO transfer factor
    • Minute volume
    • Pulse oximetry on all beds
    • End tidal pCO2
    • Transcutaneous pO2
    • Bronchoscopy and broncho-alveolar lavage
    • Histamine, methacholine and AMP challenge
    • Allergen challenge
    • Nitric oxide
    • Sputum analysis
    • Acoustic rhinometry
    close

  • Sleep
    close

     

    Our new sleep unit has 4 single bedrooms, each with:Sleep Unit at HMR

    • high-level sound-proofing, with acoustic boards, acoustic tiles and 10 cm thick fibre insulation
    • no windows
    • an entrance lobby, to maintain sound- and light-proofing when entering the room
    • remote-controlled air-conditioning, and ventilation
    • electrical trunking with separate channels for mains and low-voltage cables
    • shielding of all mains cables, and wooden beds, to prevent electromagnetic interference
    • infra-red light, and video camera
    • controlled light for <5 lux waking environment
    • microphone
    • external port for remote intravenous blood sampling
    • Embla N7000 polysomnography system (PSG) with:
      • EEG, EOG, ECG and EMG electrodes and leads
      • oximeter
      • respiratory effortEmbla N7000 polysomnography system
      • body position
      • nasal cannula
      • thermistor
      • snoring sensors

    We have 4 acquisition PCs. Each one is protected by an Uninterruptable Power Supply (UPS), and stores data on mirrored RAID hard drives. We copy the data across the network to our file server, which we back up every night. Then we copy it again to a review PC where we process it before copying the final version to external media (eg CD/DVD) or sending it to a sponsor across the internet (eg WWW/FTP).

    PSG equipment is validated in accordance with 21 CFR part 11. We have trained staff, including a PSG expert who has worked with 3 central sleep-scoring providers, and we have links with academic units experienced in sleep research.
    We work according to AASM-recommended technical standards, to produce data acceptable for peer-reviewed publication and regulatory approval.
    We can:

    • assist with study design
    • provide onsite data analysis for interim results and final reports

    Click here to find out more about sleep studies

    close

back to top ^